Our data showed that itraconazole treatment decreased C1GALT1 levels and increased Tn antigens on cell surfaces in HPAC cells (Supplementary Fig. S2A), confirming that itraconazole is also a C1GALT1 inhibitor in pancreatic cancer cells. Here, C1GALT1 is linked to familial pancreatic carcinoma.